查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922667

日本数位疗法市场报告：按应用、最终用途和地区划分（2026-2034年）

Japan Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本数位疗法市场规模达3.848亿美元。 IMARC集团预测，到2034年，该市场规模将达到20.192亿美元，2026年至2034年的复合年增长率（CAGR）为20.23%。推动市场成长的关键因素包括：关节炎、心血管疾病、糖尿病和骨质疏鬆症等各种慢性疾病的日益普遍，人工智慧（AI）和机器学习（ML）技术的进步，以及明确的指导方针和框架的建立。

数位疗法是基于软体的干预措施，旨在透过行为改变和临床支持来改善健康结果。这包括专注于改变行为模式以应对压力、焦虑和忧郁症等心理健康问题的行为疗法应用程式。它们还包括慢性病管理平台，这些平台透过药物提醒、活动追踪和个人化健康建议等功能，帮助患者监测和管理自身病情。远端患者监护也属于此类，它利用穿戴式装置和感测器远端监测患者的生命征象和健康指标。数位疗法的有效性是基于科学证据和临床试验，通常需要经过严格的测试来检验其对特定健康结果的影响。它们透过提供个人化的互动体验来强调用户参与，这些体验具有即时回馈、进度追踪和用户友好介面等功能。数位疗法旨在补充传统的医疗保健方法。它们可以与电子健康记录 (EHR) 集成，连接患者和医疗保健提供者，以实现无缝的护理协调。它们对术后復健、慢性病管理和老年护理非常有用。它们透过提供便利、经济高效的解决方案来扩大医疗保健的覆盖范围。数位疗法可以成为传统治疗方法的一种经济有效的替代方案。

日本数位疗法市场的发展趋势：

目前，对数位疗法的需求不断增长，这是推动日本市场成长的关键因素之一。数位疗法透过积极的患者参与、持续监测和个人化干预来改善健康结果。此外，关节炎、心血管疾病、糖尿病和骨质疏鬆症等各种慢性疾病的日益普遍，也推动了创新有效治疗方法的引进。数位疗法能够提供个人化的远距干预，有助于减轻日益增加的慢性疾病所带来的负担。此外，科技的快速发展，尤其是在人工智慧 (AI) 和机器学习 (ML) 领域，使得数位介入能够分析大量资料集、制定个人化治疗方案，并持续适应患者的个别需求。透过与穿戴式装置、感测器和其他连网装置的集成，数位疗法进一步增强了其收集即时健康数据的能力，为临床医生提供宝贵的信息，以辅助其做出明智的决策。此外，向基于价值的医疗保健模式和预防性护理的转变正在加速，推动了数位疗法在日本被广泛采用，成为一种经济有效的慢性病管理策略。监管机构、患者和医疗服务提供者也日益认识到投资于数位化干预措施的经济效益，这些措施不仅可以治疗慢性疾病，还能预防疾病进展。此外，不断完善的数位化疗法核准和整合指南及框架，也促进了国内市场的成长。

本报告解答的关键问题

  • 日本数位疗法市场目前发展状况如何？未来几年又将如何发展？
  • 新冠疫情对日本数位疗法市场产生了哪些影响？
  • 日本数位疗法市场按应用领域分類的市场组成是什么？
  • 日本数位疗法市场以最终用途分類的组成是怎样的？
  • 日本数位疗法市场价值链的不同阶段有哪些？
  • 日本数位疗法市场的主要驱动因素和挑战是什么？
  • 日本数位疗法市场的结构是怎么样的？主要参与者有哪些？
  • 日本数位疗法市场的竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本数位疗法市场—引言

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本数位疗法市场概览

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章 日本数位疗法市场－按应用领域细分

  • 糖尿病
  • 肥胖
  • 心血管疾病（CVD）
  • 中枢神经系统疾病
  • 呼吸系统疾病
  • 戒烟支持
  • 其他的

第七章 日本数位疗法市场－依最终用途细分

  • 病人
  • 医疗保健提供者
  • 付款人
  • 雇主
  • 其他的

第八章：日本数位疗法市场：按地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第九章：日本数位疗法市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十章主要企业概况

第十一章：日本数位疗法市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十二章附录

简介目录
Product Code: SR112026A19617

Japan digital therapeutics market size reached USD 384.8 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 2,019.2 Million by 2034 , exhibiting a growth rate (CAGR) of 20.23% during 2026-2034 . The growing prevalence of various chronic diseases like arthritis, cardiovascular complications, diabetes, and osteoporosis, rising advancements in artificial intelligence (AI) and machine learning (ML), and increasing establishment of clear guidelines and frameworks represent some of the key factors driving the market.

Access the full market insights report Request Sample

Digital therapeutics are software-based interventions designed to bring about positive health outcomes by modifying patient behavior and providing clinical support. They comprise behavioral therapy apps, which focus on modifying behavior patterns to address mental health conditions, such as stress, anxiety, and depression. They also include chronic disease management platforms, which help patients monitor and manage their conditions through features like medication reminders, activity tracking, and personalized health recommendations. They encompass remote patient monitoring, which involves the use of wearable devices and sensors to monitor the vital signs and health metrics of patients remotely. They rely on scientific evidence and clinical trials to ensure their effectiveness. They often undergo rigorous testing to validate their impact on specific health outcomes. They prioritize user engagement by providing personalized and interactive experiences. They may include features like real-time feedback, progress tracking, and user-friendly interfaces. Digital therapeutics are designed to complement traditional healthcare approaches. They can integrate with electronic health records (EHRs) and connect patients with healthcare providers for seamless coordination of care. They are useful for post-surgery recovery, chronic disease management, and eldercare. They increase access to healthcare by providing convenient and cost-effective solutions. Digital therapeutics can offer a cost-effective alternative to traditional treatments.

JAPAN DIGITAL THERAPEUTICS MARKET TRENDS:

At present, the increasing demand for digital therapeutics as they contribute to better health outcomes by actively involving patients in their care and continuously monitoring and personalized interventions represents one of the crucial factors impelling the growth of the market in Japan. Besides this, the rising prevalence of various chronic diseases like arthritis, cardiovascular complications, diabetes, and osteoporosis is driving the adoption of innovative and effective treatment modalities. Digital therapeutics addresses the increasing burden of chronic illnesses due to its ability to deliver personalized and remote interventions. In addition, the growing advancements in technology, particularly in the realms of artificial intelligence (AI) and machine learning (ML), are empowering digital interventions to analyze vast datasets, personalize treatment plans, and continuously adapt to individual patient needs. The integration of wearables, sensors, and other connected devices further enhances the capability of digital therapeutics to collect real-time health data, providing clinicians with valuable insights for informed decision-making. Apart from this, the increasing shift towards value-based care models and a focus on preventive healthcare is accelerating the adoption of digital therapeutics as a cost-efficient strategy for managing chronic conditions in the country. Regulatory bodies, patients, and healthcare providers are also recognizing the economic benefits of investing in digital interventions that not only treat but also prevent the exacerbation of chronic diseases. Additionally, the rising establishment of clear guidelines and frameworks for digital therapeutics approval and integration into mainstream healthcare is supporting the market growth in the country.

JAPAN DIGITAL THERAPEUTICS MARKET SEGMENTATION:

Application Insights:

  • To get detailed segment analysis of this market Request Sample
  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others
  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

End Use Insights:

  • Patients
  • Providers
  • Payers
  • Employers
  • Others
  • Patients
  • Providers
  • Payers
  • Employers
  • Others

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan digital therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan digital therapeutics market?
  • What is the breakup of the Japan digital therapeutics market on the basis of application?
  • What is the breakup of the Japan digital therapeutics market on the basis of end use?
  • What are the various stages in the value chain of the Japan digital therapeutics market?
  • What are the key driving factors and challenges in the Japan digital therapeutics?
  • What is the structure of the Japan digital therapeutics market and who are the key players?
  • What is the degree of competition in the Japan digital therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Digital Therapeutics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Digital Therapeutics Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Digital Therapeutics Market - Breakup by Application

  • 6.1 Diabetes
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Obesity
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 CVD
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 CNS Disease
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Respiratory Diseases
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)
  • 6.6 Smoking Cessation
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2020-2025)
    • 6.6.3 Market Forecast (2026-2034)
  • 6.7 Others
    • 6.7.1 Historical and Current Market Trends (2020-2025)
    • 6.7.2 Market Forecast (2026-2034)

7 Japan Digital Therapeutics Market - Breakup by End Use

  • 7.1 Patients
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Providers
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Payers
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Employers
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2020-2025)
    • 7.5.2 Market Forecast (2026-2034)

8 Japan Digital Therapeutics Market - Breakup by Region

  • 8.1 Kanto Region
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Breakup by Application
    • 8.1.4 Market Breakup by End Use
    • 8.1.5 Key Players
    • 8.1.6 Market Forecast (2026-2034)
  • 8.2 Kansai/Kinki Region
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Breakup by Application
    • 8.2.4 Market Breakup by End Use
    • 8.2.5 Key Players
    • 8.2.6 Market Forecast (2026-2034)
  • 8.3 Central/ Chubu Region
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Breakup by Application
    • 8.3.4 Market Breakup by End Use
    • 8.3.5 Key Players
    • 8.3.6 Market Forecast (2026-2034)
  • 8.4 Kyushu-Okinawa Region
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Breakup by Application
    • 8.4.4 Market Breakup by End Use
    • 8.4.5 Key Players
    • 8.4.6 Market Forecast (2026-2034)
  • 8.5 Tohoku Region
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Breakup by Application
    • 8.5.4 Market Breakup by End Use
    • 8.5.5 Key Players
    • 8.5.6 Market Forecast (2026-2034)
  • 8.6 Chugoku Region
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2020-2025)
    • 8.6.3 Market Breakup by Application
    • 8.6.4 Market Breakup by End Use
    • 8.6.5 Key Players
    • 8.6.6 Market Forecast (2026-2034)
  • 8.7 Hokkaido Region
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2020-2025)
    • 8.7.3 Market Breakup by Application
    • 8.7.4 Market Breakup by End Use
    • 8.7.5 Key Players
    • 8.7.6 Market Forecast (2026-2034)
  • 8.8 Shikoku Region
    • 8.8.1 Overview
    • 8.8.2 Historical and Current Market Trends (2020-2025)
    • 8.8.3 Market Breakup by Application
    • 8.8.4 Market Breakup by End Use
    • 8.8.5 Key Players
    • 8.8.6 Market Forecast (2026-2034)

9 Japan Digital Therapeutics Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Digital Therapeutics Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix